| Application no. and date | 16780833.6 (espacenet) (Federated) (European Patent Register), 20160415 | | Patent/reg. no. and date | DK/EP 3283080, 20200318 | | Publication date | 20180221 | | Priority no. and date | US 201562148691 P, 20150416, US 201562232941 P, 20150925, US 201562239400 P, 20151009 | | EP pub. no. and date |
EP 3283080 20180221 | | Effective date | | | Applicant/owner | Ionis Pharmaceuticals, Inc., 2855 Gazelle Court
Carlsbad, CA 92010, US | | Applicant ref. no. | P72430DK01 | | Inventor | RIGO, Frank, 2855 Gazelle Court
Carlsbad, CA 92010, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/7125 (2006.01) , C07H 21/02 (2006.01) , C12N 15/113 (2010.01) | | Title | SAMMENSÆTNINGER TIL MODULATION AF C9ORF72-EKSPRESSION | | Int. application no. | US2016027747 | | Int. publication no. | WO2016168592 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
